Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Why epidemiological and clinical intervention studies often give different or diverging results?
IUBMB Life. 2009 Apr;61(4):391-3. doi: 10.1002/iub.141.
IUBMB Life. 2009.
PMID: 18975376
Free article.
No abstract available.
Antidepressants and the risk of hyponatremia: a Danish register-based population study.
Leth-Møller KB, Hansen AH, Torstensson M, Andersen SE, Ødum L, Gislasson G, Torp-Pedersen C, Holm EA.
Leth-Møller KB, et al. Among authors: gislasson g.
BMJ Open. 2016 May 18;6(5):e011200. doi: 10.1136/bmjopen-2016-011200.
BMJ Open. 2016.
PMID: 27194321
Free PMC article.
Item in Clipboard
Risk assessment for recurrent venous thrombosis.
Ahlehoff O, Gislasson GH, Torp-Pedersen C, Hansen PR.
Ahlehoff O, et al. Among authors: gislasson gh.
Lancet. 2011 Mar 26;377(9771):1073; author reply 1073-4. doi: 10.1016/S0140-6736(11)60426-1.
Lancet. 2011.
PMID: 21440800
No abstract available.
Item in Clipboard
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L; DANAMI-3—PRIMULTI Investigators.
Engstrøm T, et al.
Lancet. 2015 Aug 15;386(9994):665-71. doi: 10.1016/s0140-6736(15)60648-1.
Lancet. 2015.
PMID: 26347918
Clinical Trial.
Item in Clipboard
The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design of the DANAMI 3 trial program.
Høfsten DE, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Clemmensen P, Torp-Pedersen C, Tilsted HH, Bøtker HE, Jensen LO, Køber L, Engstrøm T; DANAMI 3 Investigators.
Høfsten DE, et al.
Am Heart J. 2015 May;169(5):613-21. doi: 10.1016/j.ahj.2015.02.004. Epub 2015 Feb 14.
Am Heart J. 2015.
PMID: 25965708
Clinical Trial.
Item in Clipboard
Cite
Cite